Monday, August 22, 2016 4:28:14 PM
"Veeva’s industry cloud solutions gain momentum as companies unify business processes for faster time to market and greater compliance
As life sciences companies continue their transition from legacy on-premises and horizontal cloud software to industry-specific cloud applications, Veeva Systems (NYSE:VEEV) is strengthening its position as a fast-growing, strategic vendor in the industry across its most critical functions. According to Gartner, Veeva’s extensive cloud-based multitenant software solution set across research and development (R&D) and commercial is building the company into a strategic-level vendor for global pharma and biotech clients.1
Increased complexity in life sciences – from global stakeholder ecosystems to regulatory requirements – is driving organizations to streamline operations to be more efficient and agile. This is in an effort to accelerate innovation and get products to market faster and more effectively on a global scale. Organizations are implementing new cloud approaches to improve collaboration and provide smarter ways of working.
As a result, the industry is increasingly relying on Veeva’s applications to streamline their global business operations, with 35 of the top 50 pharmaceutical companies using Veeva Vault to unify their processes and content on a single platform in the areas of commercial, clinical, regulatory, quality and medical.2 Customers are turning to Veeva to help them improve overall business agility, compliance, and risk mitigation.
Over the next five years, Gartner expects migration to multichannel marketing to strengthen and grow within pharma and recognized Veeva as one of only two vendors to offer complete CRM products, support, and services across most of the globe.3 Veeva is in the market share leadership position of the pharma CRM vendor landscape.4
According to IDC Health Insights, Veeva’s continued momentum in the sales and marketing space has strengthened its leadership in the industry.5 “Veeva has leveraged its strong position in the life science CRM space to provide an optimized omni-channel solution for its customers, with access to its cloud-based content management, master data management, and system-wide customer data,” according to the report.
In R&D, Vault Clinical, Vault RIM, and Vault Quality are helping companies streamline their end-to-end clinical trial processes, respond faster to business changes and health authority requests, and integrate their quality processes and content. Within commercial operations, Veeva Commercial Cloud is improving how life sciences companies bring together customer data, compliant content, and multichannel engagement to market and sell more effectively. While Veeva Medical Solutions help organizations discover, target, and engage the right opinion leaders.
“There is a significant shift occurring in the industry to cloud applications that streamline and unify business processes,” said Paul Shawah, vice president of product marketing at Veeva. “Our focus on industry-specific applications is helping our customers transform their R&D, commercial, and medical operations to support faster product launches and quickly adopt new business models. Industry analysts validate that we are gaining momentum as a strategic partner to the industry.”...."
"1 Stephen Davies (Gartner: March 18, 2016), Market Guide for CRM in Pharma and Biotech
2 As of April 30, 2016.
3 Stephen Davies (Gartner: March 18, 2016), Market Guide for CRM in Pharma and Biotech
4 Stephen Davies (Gartner: March 18, 2016), Market Guide for CRM in Pharma and Biotech
5 Alan S. Louie, Ph.D., Michael Townsend, Eric Newmark (IDC Health Insights: June 2016), Business Strategy: Top Software Vendors in the Life Science Industry, 2015"
Recent VEEV News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 07:37:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 12:01:58 PM
- Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors • PR Newswire (US) • 09/05/2024 11:03:00 AM
- Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors • PR Newswire (US) • 09/05/2024 11:03:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/04/2024 08:06:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 09:56:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:56:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:55:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:52:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:49:57 PM
- Veeva to Present at Upcoming Investor Conference • PR Newswire (US) • 08/30/2024 05:45:00 PM
- Nvidia, HP, Okta, Pure Storage Drop Post-Earnings; Salesforce, Nutanix, Affirm Surge • IH Market News • 08/29/2024 10:09:21 AM
- Veeva Announces Fiscal 2025 Second Quarter Results • PR Newswire (US) • 08/28/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:04:57 PM
- U.S. Futures Edge Up as Nvidia Earnings Loom, Oil Prices Slide • IH Market News • 08/28/2024 09:52:22 AM
- New Service Center in Veeva Vault CRM Suite Unifies Sales and Service • PR Newswire (US) • 08/27/2024 11:03:00 AM
- New Service Center in Veeva Vault CRM Suite Unifies Sales and Service • PR Newswire (US) • 08/27/2024 11:03:00 AM
- Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control • PR Newswire (US) • 08/22/2024 11:03:00 AM
- Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control • PR Newswire (US) • 08/22/2024 11:03:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 09:10:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 08:27:30 PM
- Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit • PR Newswire (US) • 08/13/2024 11:03:00 AM
- Veeva to Release Fiscal 2025 Second Quarter Results on August 28, 2024 • PR Newswire (US) • 08/07/2024 08:15:00 PM
- Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption • PR Newswire (US) • 07/25/2024 01:03:00 PM
- Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption • PR Newswire (US) • 07/25/2024 01:03:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM